AbD Serotec and Thermo Fisher Scientific Sign Technology Agreement
News Feb 13, 2007
AbD Serotec, a division of MorphoSys of Munich, Germany, and Thermo Fisher Scientific Inc. announced the signing of an agreement covering the use of Thermo Scientific DyLight Dyes in combination with AbD Serotec's research antibodies to prepare a series of fluorescent reagents. The resulting products will be available through the AbD Serotec sales catalogue.
Financial details were not disclosed.
DyLight Fluorescent Dyes, available exclusively as part of Thermo Scientific's protein research product line, are an alternative to other commercially available fluorescent dyes. DyLight Dyes are water-soluble and can provide high fluorescence intensity in many applications, while maintaining photostability across a broad range of pH values.
DyLight Dyes are available over a wide range of spectra and match the output wavelengths of common fluorescence instrumentation.
AbD Serotec's product catalog comprises more than 10,000 research antibodies and immunology reagents guaranteed to perform to specification. Additionally, custom monoclonal antibodies are generated for non-therapeutic applications using the HuCAL technology.
"Fluorescent antibodies are particularly suited for detection of specific antigens in tissues or on cells and have become an indispensable tool for scientists worldwide," comments Dr. Achim Knappik Senior Director of R&D at AbD Serotec.
"Combining the vast range of research antibodies offered by AbD Serotec with Pierce Biotechnology's fluorescence technology enables AbD Serotec to further expand its wide range of fluorescent reagents, and will thus further enhance our offering in this segment," Dr Knappik said.
"DyLight Technology provides researchers a series of dyes with high fluorescence intensity and compatibility with instrumentation," said Gary Shiels, Ph.D., director of marketing for Thermo Scientific Pierce protein-analysis products.
"We are pleased AbD Serotec has selected the DyLight Technology to prepare fluorescent labels for its wide range of antibodies, further enabling the use of DyLight Technology in a wide range of applications."
When a protein named "Merlin" fails to do its job, people can develop slow-growing, life-disrupting auditory nerve tumors that can disrupt their hearing and balance. Now scientists at Cincinnati Children's have discovered much more about how Merlin does its job – by working behind the scenes through a network of more than 50 other proteins.READ MORE